YBX1 and breast carcinoma: On the contrary, Goodarzi et al. highlighted that endogenous tRFs suppress breast cancer progression via displacement of YBX1 [27], while the CU1276 (3′-tRF of from tRNAGlyGCC), which is significantly downregulated in lymphoma cell lines, was documented to suppress lymphoma cells’ proliferation [28].